2408872-84-2

2408872-84-2 structure
2408872-84-2 structure
  • Name: Cimpuciclib tosylate
  • Chemical Name: Cimpuciclib tosylate
  • CAS Number: 2408872-84-2
  • Molecular Formula: C37H43FN8O4S
  • Molecular Weight: 714.85
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage CDK
  • Create Date: 2022-11-22 09:10:46
  • Modify Date: 2024-04-02 18:28:34
  • Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].

Name Cimpuciclib tosylate
Description Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].
Related Catalog
Target

CDK4:0.49 nM (IC50)

CDK6:9.56 nM (IC50)

In Vitro Cimpuciclib (example 63, 141.2 nM, 6 days) tosylate inhibits proliferation of colo205 cells[1]. Cell Proliferation Assay[1] Cell Line: Colo205 cells Concentration: 0-500 nM approximately Incubation Time: 6 days Result: Inhibited cell proliferation with an IC50 value of 141.2 nM.
In Vivo Cimpuciclib (example 63, 50 mg/kg, oral gavage, twice a week) tosylate inhibits tumor growth in colo205 tumor-bearing mice[1]. Cimpuciclib (5 mg/kg for rats, 50 mg/kg for colo205 tumor-bearing mice, oral administration) tosylate shows slow metabolic rate and maintains high concentration in the plasma[1]. Animal Model: Colo205 tumor-bearing mice[1] Dosage: 50 mg/kg, twice a week Administration: Oral gavage Result: Inhibited tumor growth by 93.63% Animal Model: Rats, colo205 tumor-bearing mice[1] Dosage: 5 mg/kg for rats, 50 mg/kg for colo205 tumor-bearing mice. Administration: Oral administration Result: Pharmacokinetic profile of Cimpuciclib (example 63). dose Cmax (ng/mL) Tmax (h) AUC0-24 (ng/mL•h) t1/2 (h) 5 mg/kg (rats) 559.7 6 5414 2.4 50 mg/kg (mice) 7960 1 136782 14.8
References

[1]. Liu Shiqiang, et al. Preparation of benzimidazole compound as kinase inhibitor. Patent WO 2018045956.

Molecular Formula C37H43FN8O4S
Molecular Weight 714.85
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.